药物联合使用:21 世纪延长抗生素寿命的策略。

Drug combinations: a strategy to extend the life of antibiotics in the 21st century.

机构信息

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.

M. G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.

出版信息

Nat Rev Microbiol. 2019 Mar;17(3):141-155. doi: 10.1038/s41579-018-0141-x. Epub 2019 Jan 25.

Abstract

Antimicrobial resistance threatens a resurgence of life-threatening bacterial infections and the potential demise of many aspects of modern medicine. Despite intensive drug discovery efforts, no new classes of antibiotics have been developed into new medicines for decades, in large part owing to the stringent chemical, biological and pharmacological requisites for effective antibiotic drugs. Combinations of antibiotics and of antibiotics with non-antibiotic activity-enhancing compounds offer a productive strategy to address the widespread emergence of antibiotic-resistant strains. In this Review, we outline a theoretical and practical framework for the development of effective antibiotic combinations.

摘要

抗菌药物耐药性威胁着危及生命的细菌感染的死灰复燃,以及现代医学许多领域的潜在崩溃。尽管进行了密集的药物发现工作,但几十年来,没有新的抗生素类别被开发成新药,这在很大程度上是由于有效抗生素药物在化学、生物学和药理学方面的严格要求。抗生素与非抗生素活性增强化合物的组合为解决广泛出现的抗生素耐药菌株提供了一种富有成效的策略。在这篇综述中,我们概述了开发有效抗生素组合的理论和实践框架。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索